DE3616054C2 - - Google Patents
Info
- Publication number
- DE3616054C2 DE3616054C2 DE19863616054 DE3616054A DE3616054C2 DE 3616054 C2 DE3616054 C2 DE 3616054C2 DE 19863616054 DE19863616054 DE 19863616054 DE 3616054 A DE3616054 A DE 3616054A DE 3616054 C2 DE3616054 C2 DE 3616054C2
- Authority
- DE
- Germany
- Prior art keywords
- trituration
- treatment
- suis
- gelatin
- side effects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000001665 trituration Methods 0.000 claims description 15
- 108010010803 Gelatin Proteins 0.000 claims description 7
- 229920000159 gelatin Polymers 0.000 claims description 7
- 239000008273 gelatin Substances 0.000 claims description 7
- 235000019322 gelatine Nutrition 0.000 claims description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 241000207963 Harpagophytum Species 0.000 claims description 5
- 230000001632 homeopathic effect Effects 0.000 claims description 5
- 229940126601 medicinal product Drugs 0.000 claims description 3
- 230000000694 effects Effects 0.000 description 9
- 239000003814 drug Substances 0.000 description 7
- 210000000845 cartilage Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 239000003435 antirheumatic agent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 229940124599 anti-inflammatory drug Drugs 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- FZKCAHQKNJXICB-UHFFFAOYSA-N 2,1-benzoxazole Chemical compound C1=CC=CC2=CON=C21 FZKCAHQKNJXICB-UHFFFAOYSA-N 0.000 description 1
- 235000019890 Amylum Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000254191 Harpagophytum procumbens Species 0.000 description 1
- 229920001499 Heparinoid Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940051880 analgesics and antipyretics pyrazolones Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000002554 heparinoid Substances 0.000 description 1
- 229940025770 heparinoids Drugs 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 208000018937 joint inflammation Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 238000012153 long-term therapy Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical class O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 239000007885 tablet disintegrant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863616054 DE3616054A1 (de) | 1986-05-13 | 1986-05-13 | Homoeopathisches arzneimittel zur behandlung von rheumatischen erkrankungen |
| CH480486A CH669114A5 (de) | 1986-05-13 | 1986-12-01 | Homoeopathisches arzneimittel zur behandlung von rheumatischen erkrankungen. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863616054 DE3616054A1 (de) | 1986-05-13 | 1986-05-13 | Homoeopathisches arzneimittel zur behandlung von rheumatischen erkrankungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3616054A1 DE3616054A1 (de) | 1987-11-19 |
| DE3616054C2 true DE3616054C2 (enExample) | 1991-01-10 |
Family
ID=6300705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19863616054 Granted DE3616054A1 (de) | 1986-05-13 | 1986-05-13 | Homoeopathisches arzneimittel zur behandlung von rheumatischen erkrankungen |
Country Status (2)
| Country | Link |
|---|---|
| CH (1) | CH669114A5 (enExample) |
| DE (1) | DE3616054A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4327147C2 (de) * | 1993-08-12 | 1996-12-19 | Klinge Co Chem Pharm Fab | Arzneimittelzusammensetzung, welche neben dem Wirkstoff ein Gemisch aus Gelatine unterschiedlicher Löslichkeit enthält |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4436723A (en) * | 1980-09-24 | 1984-03-13 | Juanita Nepon | Arthritis composition of matter, and methods of preparing and utilizing same |
-
1986
- 1986-05-13 DE DE19863616054 patent/DE3616054A1/de active Granted
- 1986-12-01 CH CH480486A patent/CH669114A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3616054A1 (de) | 1987-11-19 |
| CH669114A5 (de) | 1989-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0254289B1 (de) | Mittel zur Behandlung von Arthrosen | |
| DE3880762T2 (de) | Orale, acetaminophen enthaltende zusammensetzung mit gesteuerter arzneistoff-freisetzung und verfahren zu ihrer herstellung. | |
| DE69704426T2 (de) | Verfahren zur herstellung von medizinischem kaugummi mit einem guten geschmack, enthaltend eine einschlussverbindung | |
| DE69106549T2 (de) | Thrombin-Zusammensetzung zur oralen Verabreichung. | |
| DE68903846T2 (de) | Neue galenische form von fenofibrat. | |
| DE3879080T2 (de) | Pharmazeutische matrix mit verzoegerter freisetzung und verfahren. | |
| EP0740938B1 (de) | Verwendung von Prolin als einziger therapeutischer Wirkstoff zur Herstellung eines Arzneimittels zur Behandlung von rheumatischen Erkrankungen und von chronischen und traumatisch bedingten Schmerzzuständen | |
| DE69829042T2 (de) | Nicotinsäurezusammensetzungen enthaltender Starterkit | |
| DE2224534B2 (de) | Pharmazeutisches praeparat mit langsamer wirkstoffabgabe | |
| DE69814850T2 (de) | Paracetamol enthaltende schlickbare tablette | |
| EP2974733B1 (de) | Kombination von Baldrianwurzelextrakt und Lavendelöl zur Verwendung zur Behandlung von Schlafstörungen | |
| EP0250648A2 (de) | Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen | |
| EP0108882B1 (de) | Presslinge mit retardierter Wirkstofffreisetzung und Verfahren zu deren Herstellung | |
| DE69730214T2 (de) | Zusammensetzung und verfahren zur behandlung von herpes simplex | |
| EP0164571B1 (de) | Retardformen des alpha-(2,5-Dimethoxy-phenyl)-beta-lycinamido-äthanols und Verfahren zu ihrer Herstellung | |
| DE69003960T2 (de) | Die Verwendung von deacetyliertem Chitin zur Herstellung eines Medikamentes für die Behandlung von entzündliche Krankheiten. | |
| DE3616054C2 (enExample) | ||
| EP2161022B1 (de) | Herstellung von Phosphatbindern und auf diese Weise hergestellte Phosphatbinder | |
| DE4300969C2 (de) | Verwendung von Malotilat zum Beschleunigen der Wundheilung bei Hautverbrennungen | |
| DE60310125T2 (de) | Feste mucoadhesive zusammensetzung | |
| DE69911427T2 (de) | Komprimierte zusammensetzungen mit geklärter xanthangummi | |
| DE69103724T2 (de) | Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren. | |
| EP0720854A1 (de) | Verwendung von Gallensäuren zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen der Haut | |
| EP1210945B1 (de) | Arzneimittelzubereitung mit antiarteriosklerotischer Wirkung | |
| AT525585B1 (de) | Kräutermischung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |